LaFemina et al., Antimicrobial Agents & Chemotherapy, vol. 39(2), pp. 320-324 (1995), "Inhibition of human immunodeficiency virus integrase by bis-catechols". |
Cushman et al., J. Med. Chem., vol. 38 (1995), pp. 443-452, "Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase". |
Mazumder et al., Biochemistry, vol. 34 (1995), pp. 15111-15122, "Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase". |
Mazumder et al., J. Med. Chem., vol. 39 (1996), pp. 2472-2481, "Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease". |
Mazumder et al., Molecular Pharmacology, vol. 49 (1996), pp. 621-628, "Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase". |
Kusumoto et al., C.A. 120(19):238888s, "A comparative study on the inhibitory effects of flavonoids and alkaloids on reverse transcriptases of different retroviruses". |
Mazumder et al., AIDS Research and Human Retroviruses, vol. 11(1), pp. 115-125 (1995), "Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation . . . ". |
Mazumder et al., Proc. Nat'l Acad. Sci. USA, vol. 91, pp. 5771-5775 (1994), "Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate". |
Carteau et al., Biochemical Pharm., vol. 47(10), pp. 1821-1826 (1994), "Inhibition of the in vitro integration of moloney murine leukemia virus DNA by the DNA minor groove binder netropsin". |
Fesen et al., Proc. Nat'l Acad. Sci. USA, vol. 90 (1993), pp. 2399-2403, "Inhibitors of human immunodeficiency virus integrase". |
Farnet et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 9742-9747, "Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules". |
Lutzke et al., Proc. Nat'l Acad. Sci. USA, vol. 92 (1995), pp. 11456-11460, "Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library". |
Ojwang et al., Antimicrobial Agents & Chemotherapy, vol. 39(11), pp. 2426-2435 (1995), "T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor . . . ". |
Eich et al., J. Med. Chem., vol. 39 (1996), pp. 86-95, "(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase". |
Konig et al., J. of Bioenergetics & Biomembranes, vol. 25(5), pp. 537-545 (1993), "Effects of equisetin on rat liver mitochondria: evidence for inhibition of substrate anion carriers of the inner membrane". |
Philipps et al., J. Am. Chem. Soc., vol. 111 (1989), pp. 8223-8231, "Characterization of the fusarium toxin equisetin: the use of phenylboronates in structure assignment". |
Turos et al., J. Am. Chem. Soc., vol. 111 (1989), pp. 8231-8236, "Total synthesis of the fusarium toxin equisetin: proof of the stereochemical relationship of the tetramate and terpenoid sectors". |
Hazuda et al., Nucleic Acids Research, vol. 22(6), pp. 1121-1122 (1994), "A novel assay for the DNA strand-transfer reaction of HIV-1 integrase". |
Burke et al., J. Med. Chem., vol. 38 (1995), pp. 4171-4178, "Hydroxylated aromatic inhibitors of HIV-1 integrase". |
Hazuda et al., J. of Virology, vol. 71(1), pp.807-811 (1997), "Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds". |
Fesen et al., Biochemical Pharma., vol. 48(3), pp. 595-608 (1994), "Inhibition of HIV-1 integrase by flavones, caffeic acid phenthyl ester (cape) and related compounds". |
Carteau et al., Archives of Biochemistry & Biophysics, vol. 305(2), pp. 606-610 (1993), "Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction". |
Robinson, Jr., et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 6326-6331, "Inhibitors of HIV-1 replication that inhibit HIV integrase". |
PRNewswire, Sep. 17, 1996, "Aronex reports results for lead anti-HIV integrase inhibitor compound". |